ETF Battles: Which Pharmaceutical ETF Should You Buy? Watch PPH vs. PJP vs. XPH!

In this episode of ETF Battles, Ron DeLegge @ETFguide referees an audience requested triple-header contest between a trio of pharmaceutical ETFs from Invesco (PJP), State Street Global Advisors (SSgA) and VanEck (PPH). Program judges David Dierking with TheStreet.com and Tom Psarofagis with Bloomberg Intelligence judge the ETF match-up, sharing their investing research insights. Each ETF is judged against the other in key categories like cost, exposure strategy, performance and a mystery category. Find out who wins the battle!*********ETF Battles is sponsored by: Direxion Daily Leveraged & Inverse ETFs. Know the risks. Proceed Boldly. Visit http://www.Direxion.com